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Purpose or Objective: Proton and ion therapy require 
accurate prediction of particle ranges in tissue. In current 
clinical practice, computed tomography (CT) images are 
voxel-wise converted to ion-stopping power ratio maps using 
direct heuristic relations. The general validity of these 
approaches is, however, limited due to the different physical 
regimes of photon and ion interaction. Using a more 
sophisticated method based on dual-energy CT (DECT), which 
provides access to the physical quantities influencing photon 
attenuation, Hünemohr et al. (2014) reported an improved 
ion-range prediction for homogeneous tissue surrogates. 
Here, we present a major modification of the latter method, 
enabling a proper treatment of heterogeneities and mixtures 
on several structural levels, which represent a crucial feature 
of the realistic clinical situation. 
 
Material and Methods: We treat the stopping-power ratio as 
the product of the electron density relative to water and a 
correction factor that implicitly involves the logarithmic 
dependence on the mean excitation energy (I-value). The 
relative electron density, being an important parameter in 
both photon and ion energy loss, can be derived directly from 
DECT scans using a universal and robust method. The 
correction factor, however, has to be determined with an 
empirical method. For this purpose, we propose to use the 
information from CT images that is complementary to the 
relative electron density, i.e. the electronic photon 
absorption cross section relative to water. Using the 
attenuation sum rule and Bragg’s additivity rule, the relative 
cross sections and correction factors were calculated for 
single elements, tissue base materials like water, lipid, etc. 
and tabulated real tissues. 
 
Results: For a therapeutic beam energy of 200 MeV/u, the 
correction factor varies between 1.15 and 0.70 for single 
elements with atomic numbers between 1 and 100. Building 
up compounds from a certain number of elements, a 
maximum spread of possible values for the correction factor 
can be quoted for a given relative cross section, due to the 
mathematical structure of the variable space. In practice, 
this could be used as an uncertainty estimate for a given 
calibration. The accessible variable space is drastically 
reduced by admitting only tissue base materials such as 
water, lipids and hydroxylapatite. The space is further 
reduced by admitting only mixtures of real tissue materials. 
For human tissue, the correction factor is thus limited overall 
to a small range around one (0.96 - 1.02). 
 
Conclusion: With the definition of the correction factor in 
the stopping-power ratio prediction and its relation to the 
relative cross section, a mathematically rigorous treatment 
of tissue mixtures was made possible. Such mixtures 
influence CT imaging of patients e.g. in the form of volume 
averaging in a CT voxel. This thorough treatment of mixtures 
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Purpose or Objective: The development of a synthetic CT 
(synCT) derived from MR images is necessary to support MR-
only treatment planning. While we have previously developed 
a synCT solution for the brain, no clear quality assurance 
workflow currently exists for synCT validation. This work uses 
a novel MR-CT compatible 3D anthropomorphic skull phantom 
(Fig 1A) to evaluate the uncertainty in an MR-only workflow 
in the brain. 
 
Material and Methods: MR images of the phantom were 
acquired on a 1.0T High-Field Open MR-Simulator (Philips 
Medical Systems, Cleveland, OH). Triple echo ultra-short 
echo time combined with mDixon (UTE/Dixon), T1-FFE, T2-
TSE, and FLAIR images MR images were acquired using an 8-
channel head coil. Bone-enhanced images were generated via 
an optimal weighted combination of inverted UTE and 
water/fat maps automatically generated from mDixon. 
Images were then semi-automatically segmented using 
Gaussian mixture modeling before generating synCTs via a 
previously described region-specific, voxel-based, weighted 
summation method. SynCTs were validated by calculating the 
mean absolute error (MAE) between SynCT and CT-SIM. DRRs 
from CT-SIM and SynCT were generated of the phantom and 
geometric fidelity was assessed via bounding box and 
landmark analysis. On-board planar (MV/KV) and volumetric 
(CBCT) images were acquired of the phantom and rigid 
registration was compared between datasets across three 
linear accelerator platforms. 
 
Results: The MAE of the synCT for the skull phantom (Fig 1E) 
was 131 HU. Embedded landmarks between the phantom CT-
SIM DRRs and SynCT DRRs for both right lateral and anterior 
projections were <1 mm (1G). However, slight image 
intensity variations were observed across the DRRs in the 
synCT as compared to the CT-SIM. Bounding box analysis of 
the skull revealed that anterior-posterior DRRs were <1 mm 
different between synCT and CT-SIM while lateral DRRs had a 
slightly higher uncertainty in the anterior-posterior dimension 
(~2 mm). MV and KV planar image registrations were within 
0.7 mm for all linear accelerators. CBCT/CT-SIM and 




Conclusion: DRRs yielded comparable geometry between CT 
and synCT. Future work will involve an intensity 
normalization for synCT DRRs. Image registrations were 
within clinically acceptable ranges. Efforts are needed to 
combine geometric and dosimetric errors of the entire synCT 
pipeline; establishing QA workflows to quantify these 
uncertainties are necessary for MR-only treatment planning. 
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Purpose or Objective: Due to the spatial heterogeneity of 
tumors, the change of tumor size and the whole-tumor 
average method used in routine care do not reliably identify 
patients’ histologic response to therapy in sarcomas, thus 
compromising tumor control in the context of precision 
medicine. In this study, we investigated the utility of 
dynamic contrast-enhanced MRI (DCE-MRI) combined with the 
voxel-wise image analysis approach as an early predictive 
biomarker for efficacy of neoadjuvant chemoradiation 
therapy in sarcoma. 
 
Material and Methods: Serial DCE-MRI scans were performed 
on days before therapy (time point 1, TP1) and after 2 weeks 
of chemoradiation therapy (time point 2, TP2) in twelve 
